The Drugs Controller General of India (DCGI) on Thursday granted regular market approval for Covid vaccines - Covishield and Covaxin - for use in adult population with certain conditions.
The Drugs Controller General of India (DCGI) will take a final decision on granting market approval to two Covid-19 vaccines in the country. Union health secretary Rajesh Bhushan said the Subject ...
This has reduced the timeline for the approval of blood banks." New Delhi: The Drugs Controller General of India (DCGI) has reduced the time required for blood bank licensing from a year to a ...
Brinton had recently received the nod from Drugs Controller General of India (DCGI) to launch Favipiravir 400 mg tablets under the brand name Faviton. Favipiravir is currently being used in the ...
New Delhi: The Drugs Controller General of India (DCGI) has directed the cosmetics ... Importers are having issues related to products approval. The regulatory protocol is much easier in other ...
DCGI Dr Rajeev Singh Raghuvanshi in a circular said that a meeting is scheduled with ... Madhya Pradesh. Besides, delays in the regulatory approval process can also lead to delay in bringing new and ...
The Drug-Controller General of India (DCGI) has given the go-ahead for the first clinical trials designed to test stem cell products. Stempeutics Research of Bangalore launched a combined phase 1 ...
Earlier this month, regulator DCGI cautioned against the consumption ... How can a medicine approved by the drug control authority be banned, Delhi High Court asked today, as the government ...